| abstract |
ASSAY FOR HUMAN BREAST CANCER Abstract Methods are disclosed for detecting, staging and monitoring breast cancer. The methods involve de-termining the amount of certain antigens, designated W1 and W9, in serum via quantitative immunoassays using anti-W1 or anti-W9 monoclonal antibodies. The amount detected is compared with amounts of the antigen found in normal sera, sera from breast cancer patients of pre-determined stage, or other samples of the patient's own serum, depending upon the purpose of the assay. |